Scholar Rock Holding Corporation

NasdaqGS:SRRK Stock Report

Market Cap: US$1.2b

Scholar Rock Holding Management

Management criteria checks 2/4

Scholar Rock Holding's CEO is Jay Backstrom, appointed in Oct 2022, has a tenure of 1.42 years. total yearly compensation is $7.50M, comprised of 2.1% salary and 97.9% bonuses, including company stock and options. directly owns 0.033% of the company’s shares, worth $388.24K. The average tenure of the management team and the board of directors is 2 years and 7.4 years respectively.

Key information

Jay Backstrom

Chief executive officer

US$7.5m

Total compensation

CEO salary percentage2.1%
CEO tenure1.4yrs
CEO ownership0.03%
Management average tenure2yrs
Board average tenure7.4yrs

Recent management updates

Recent updates

Scholar Rock: Solid Data And Good Prospects

Jan 12

Scholar Rock Holding Corporation's (NASDAQ:SRRK) Share Price Not Quite Adding Up

Apr 19
Scholar Rock Holding Corporation's (NASDAQ:SRRK) Share Price Not Quite Adding Up

Scholar Rock: OLE Data In SMA Coupled With New CEO Make It A Buy

Oct 20

Jay Backstrom is the new CEO at Scholar Rock

Sep 20

Scholar Rock initiated at buy at Truist on platform for rare diseases and oncology

Jul 12

Brokers Are Upgrading Their Views On Scholar Rock Holding Corporation (NASDAQ:SRRK) With These New Forecasts

May 21
Brokers Are Upgrading Their Views On Scholar Rock Holding Corporation (NASDAQ:SRRK) With These New Forecasts

Broker Revenue Forecasts For Scholar Rock Holding Corporation (NASDAQ:SRRK) Are Surging Higher

Mar 08
Broker Revenue Forecasts For Scholar Rock Holding Corporation (NASDAQ:SRRK) Are Surging Higher

Scholar Rock Holding Corporation (NASDAQ:SRRK) Analysts Are More Bearish Than They Used To Be

May 15
Scholar Rock Holding Corporation (NASDAQ:SRRK) Analysts Are More Bearish Than They Used To Be

Is Scholar Rock Holding (NASDAQ:SRRK) Using Too Much Debt?

May 07
Is Scholar Rock Holding (NASDAQ:SRRK) Using Too Much Debt?

If You Had Bought Scholar Rock Holding (NASDAQ:SRRK) Stock A Year Ago, You Could Pocket A 283% Gain Today

Mar 01
If You Had Bought Scholar Rock Holding (NASDAQ:SRRK) Stock A Year Ago, You Could Pocket A 283% Gain Today

We Think Scholar Rock Holding (NASDAQ:SRRK) Can Afford To Drive Business Growth

Jan 05
We Think Scholar Rock Holding (NASDAQ:SRRK) Can Afford To Drive Business Growth

Scholar Rock EPS misses by $0.23, misses on revenue

Nov 09

Scholar Rock Is At Phase 2, $1 Billion Is Too Expensive

Nov 04

Scholar Rock prices ~$200M equity offering.

Oct 29

CEO Compensation Analysis

How has Jay Backstrom's remuneration changed compared to Scholar Rock Holding's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023n/an/a

-US$166m

Sep 30 2023n/an/a

-US$159m

Jun 30 2023n/an/a

-US$160m

Mar 31 2023n/an/a

-US$166m

Dec 31 2022US$7mUS$159k

-US$135m

Compensation vs Market: Jay's total compensation ($USD7.50M) is above average for companies of similar size in the US market ($USD3.31M).

Compensation vs Earnings: Insufficient data to compare Jay's compensation with company performance.


CEO

Jay Backstrom (68 yo)

1.4yrs

Tenure

US$7,495,992

Compensation

Dr. Jay Thomas Backstrom, M.D., M.P.H., serves as Non-Executive Director of LAVA Therapeutics N.V. since June 2022. He serves as Director at Be Biopharma, Inc. since December 2021. He had served as a Direc...


Leadership Team

NamePositionTenureCompensationOwnership
Jay Backstrom
President1.4yrsUS$7.50m0.033%
$ 388.2k
Edward Myles
CFO, COO & Treasurer3.7yrsUS$3.11m0.032%
$ 374.6k
Junlin Ho
General Counsel & Corporate Secretary4yrsUS$2.13m0.082%
$ 956.8k
Mo Qatanani
Chief Scientific Officerless than a yearno data0.013%
$ 156.7k
Rushmie Nofsinger
Vice President of Corporate Affairs & Investor Relationsno datano datano data
Caryn Parlavecchio
Chief Human Resources Officer2.6yrsno data0.038%
$ 441.9k
Lisa Price
Senior Vice President of Human Resourcesno datano datano data
Erin Moore
Senior Vice President of Financeno datano datano data
Ryan Iarrobino
Senior Vice President of Clinical Development & Operations4yrsno datano data
Jing Marantz
Chief Medical Officer1.3yrsno datano data
Tracey Sacco
Chief Commercial Officer1.1yrsno datano data

2.0yrs

Average Tenure

50yo

Average Age

Experienced Management: SRRK's management team is considered experienced (2 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Jay Backstrom
President1.4yrsUS$7.50m0.033%
$ 388.2k
Michael Gilman
Independent Director & Member of Scientific Advisory Board10.3yrsUS$199.22k0.048%
$ 561.9k
Timothy Springer
Member of Scientific Advisory Boardno dataUS$48.97kno data
Amir Nashat
Independent Director11.4yrsUS$145.67k0.034%
$ 399.8k
Jeffrey Flier
Independent Director & Member of Scientific Advisory Board7.4yrsUS$156.27k0.012%
$ 135.1k
Leonard Zon
Member of Scientific Advisory Boardno datano datano data
Kristina Burow
Independent Director9.6yrsUS$156.87k0.0069%
$ 80.1k
Joan Massague
Member of Scientific Advisory Boardno datano datano data
David Hallal
Independent Chairman of the Board6.7yrsUS$315.93k0.37%
$ 4.4m
Scott L. Friedman
Member of Scientific Advisory Boardno datano datano data
Barry Coller
Member of Scientific Advisory Boardno datano datano data
Joshua Reed
Independent Director3yrsUS$154.67k0%
$ 0

7.4yrs

Average Tenure

68yo

Average Age

Experienced Board: SRRK's board of directors are considered experienced (7.4 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.